TAREXTUMAB
UNII 333YMY788E

Substance Identification & Data

This profile provides standardized clinical and technical data for Tarextumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 333YMY788E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1359940-55-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

333YMY788E

CAS Registry Number

1359940-55-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TAREXTUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C95719

National Cancer Institute reference terminology for clinical and research data.

INN ID

9762

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-112

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tarextumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TAREXTUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN NOTCH (RECEPTOR) NOTCH2/NOTCH (RECEPTOR) NOTCH3) (HUMAN OMP-59R5 HEAVY CHAIN), DISULFIDE WITH HUMAN OMP-59R5 LIGHT CHAIN, DIMER

TAREXTUMAB [INN]

TAREXTUMAB [USAN]

TAREXTUMAB [WHO-DD]